4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-21-015487
EVP, Chief Medical Officer acquired 22,013 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Shah Jatin · EVP, Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-02-25 | Grant or award : show line 1 in the form | +22,013 | 107,691 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-02-25 | Grant or award : show line 2 in the form Stock Option (right to buy) | +59,968 | $14.56 | 2031-02-24 | 59,968 | 59,968 | D |
Loading xslF345X03/doc4.xml…